Schedule 13G ownership disclosure

INVIVO THERAPEUTICS HOLDINGS CORP.

Security class unavailable · CUSIP: 46186M407

Event date: 2018-06-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
163,000
Percent of class
8.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-18-000091
Form type
SC 13G
Filer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK
CIK 1292519
Filed
Jun 25, 2018
Reporting period
Jun 21, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub